Nurexone Biologic Inc
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Nurexone Biologic Inc
-
Narrated by:
-
By:
About this listen
Nurexone Biologic Inc (OTCQB: NRXBF) is a TSXV, OTCQB, and Frankfurt-listed biotech company focused on developing regenerative exosome-based therapies for central nervous system injuries. Lior Shaltiel, CEO of Nurexone Biologic, joins us today to share and explain Nurexone's innovative and promising research on its lead candidate, XOP10.
View Podcast Transcript
What listeners say about Nurexone Biologic Inc
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.